Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.44 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17433647 | 0.98 | CYP1A2 (0.54) | CYP1A2PAOXTSHRTHRBLMNA | |
| SCHEMBL12538257 | 0.98 | CYP1A2 (0.54) | CYP1A2PAOXTSHRTHRBLMNA | |
| SCHEMBL284862 | 0.91 | PAOX (0.58) | CYP1A2PAOXTSHRTHRBLMNA | |
| SCHEMBL19816433 | 0.91 | PAOX (0.58) | CYP1A2PAOXTSHRTHRBLMNA | |
| SCHEMBL9170595 | 0.91 | PAOX (0.58) | CYP1A2PAOXTSHRTHRBLMNA | |
| SCHEMBL5433574 | 0.85 | — | — | |
| SCHEMBL4759428 | 0.85 | TSHR (0.52) | CYP1A2TSHRLMNAALDH1A1PTGS1 | |
| SCHEMBL614868 | 0.85 | TSHR (0.50) | CYP1A2TSHRLMNAALDH1A1RECQL | |
| SCHEMBL20010546 | 0.85 | CYP1A2 (0.58) | CYP1A2PAOXTSHRTHRBLMNA | |
| Hexadecylamine SCHEMBL28285653 | 0.84 | PAOX (0.50) | CYP1A2PAOXTSHRLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3836971-A1 | CONJUGATES AND METHODS OF USING THE SAME | Flagship Pioneering Innovations V, Inc. (US) | 2021-06-23 | — | — | EP | claimed |
| US-20210162057-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-06-03 | — | — | US | claimed |
| WO-2020037009-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2020-02-20 | — | — | WO | claimed |
| US-11998610-B2 | Conjugates and methods of using the same | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-20240141397-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | AGAIN BIO APS (DK) | 2024-05-02 | — | — | US | disclosed |
| EP-3836971-A1 | CONJUGATES AND METHODS OF USING THE SAME | Flagship Pioneering Innovations V, Inc. (US) | 2021-06-23 | — | — | EP | disclosed |
| US-20210162057-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-06-03 | — | — | US | disclosed |
| WO-2020037009-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2020-02-20 | — | — | WO | disclosed |
| US-10490748-B2 | Rectifying element, method for producing same, and wireless communication device | TORAY INDUSTRIES, INC. (JP) | 2019-11-26 | — | — | US | disclosed |
| US-20190300918-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | AGAIN BIO APS (DK) | 2019-10-03 | — | — | US | disclosed |
| EP-3314002-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | Genomatica, Inc. (US) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016209883-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | GENOMATICA, INC. (US) | 2016-12-29 | — | — | WO | disclosed |
| US-20160035457-A1 | FIELD EFFECT TRANSISTOR | TORAY INDUSTRIES, INC. (JP) | 2016-02-04 | — | — | US | disclosed |
| EP-2975649-A1 | FIELD EFFECT TRANSISTOR | Toray Industries, Inc. (JP) | 2016-01-20 | — | — | EP | disclosed |
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | disclosed |
| CN-1510030-A | Preparations of 3-(methylthio) propylaldehyde and 2-hydroxy-4-(methylthio) propyl cyanides | 诺沃斯国际公司 | 2004-07-07 | — | — | CN | disclosed |
| US-20030139361-A1 | Drug for gene therapy | HISAMITSU PHARMACEUTICAL CO., LTD (JP) | 2003-07-24 | — | — | US | disclosed |
| EP-1252897-A1 | DRUGS FOR GENE THERAPY | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2002-10-30 | — | — | EP | disclosed |
| CN-1092184-C | Process for preparing 3- (methylthio) propanal | NOVAS INTERNAT INC (US) | 2002-10-09 | — | — | CN | disclosed |
| EP-0428000-A1 | Fluorogenic substrates for the detection of proteolytic enzyme activity | ABBOTT LABORATORIES (US) | 1991-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11998610-B2 | Conjugates and methods of using the same | CD47, CD44, CD74 | CYP1A2 3706/4885PAOX 2772/4885TSHR 2775/4885 |
| US-20210162057-A1 | CONJUGATES AND METHODS OF USING THE SAME | CD47, CD44, CD74 | CYP1A2 3706/4885PAOX 2772/4885TSHR 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.